Themis Medicare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
110.45
-2.2 (-1.95%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 34.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wanbury
Lincoln Pharma.
Kopran
Themis Medicare
Shukra Pharma.
Bajaj Healthcare
Syncom Formul.
Sigachi Indust.
Bharat Parenter.
Accent Microcell
Remus Pharma.

Why is Themis Medicare Ltd ?

1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 100.09 times
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 100.09 times
2
Poor long term growth as Operating profit has grown by an annual rate -175.34% of over the last 5 years
3
Positive results in Mar 26
  • PBT LESS OI(Q) At Rs 5.39 cr has Grown at 187.5% (vs previous 4Q average)
  • PAT(Q) At Rs 8.89 cr has Grown at 314.7% (vs previous 4Q average)
4
Risky - Negative Operating Profits
  • The company has recorded a negative EBIT of Rs. -9.94 cr
  • Over the past year, while the stock has generated a return of -4.33%, its profits have fallen by -93.3%
  • The stock is trading risky as compared to its average historical valuations
5
43.39% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
  • The proportion of pledged holdings has increased by 40.96% over the last quarter
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Themis Medicare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Themis Medicare for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Themis Medicare
-4.33%
-0.08
55.58%
Sensex
-2.63%
-0.19
13.57%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.21%
EBIT Growth (5y)
-175.34%
EBIT to Interest (avg)
4.58
Debt to EBITDA (avg)
10.13
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.86
Tax Ratio
40.21%
Dividend Payout Ratio
15.43%
Pledged Shares
43.39%
Institutional Holding
0.02%
ROCE (avg)
11.55%
ROE (avg)
12.31%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
510
Industry P/E
37
Price to Book Value
2.54
EV to EBIT
-111.07
EV to EBITDA
1104.04
EV to Capital Employed
2.26
EV to Sales
3.23
PEG Ratio
NA
Dividend Yield
0.45%
ROCE (Latest)
-2.03%
ROE (Latest)
0.50%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
PBT LESS OI(Q)

At Rs 5.39 cr has Grown at 187.5% (vs previous 4Q average

PAT(Q)

At Rs 8.89 cr has Grown at 314.7% (vs previous 4Q average

-8What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 9.15 cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.92 times

NET SALES(Q)

At Rs 76.53 cr has Fallen at -9.3% (vs previous 4Q average

NON-OPERATING INCOME(Q)

is 40.51 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Themis Medicare

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 5.39 cr has Grown at 187.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -6.16 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 8.89 cr has Grown at 314.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -4.14 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Here's what is not working for Themis Medicare

Net Sales - Quarterly
At Rs 76.53 cr has Fallen at -9.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 84.35 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Non Operating Income - Quarterly
is 40.51 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 9.15 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Lowest at 1.92 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 3.67 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income